Literature DB >> 7885584

Risk factors and outcomes for ischemic stroke.

R L Sacco1.   

Abstract

Stroke continues to have a great impact on public health in the United States. Stroke is frequent, recurring, and is more often disabling than fatal. The annual incidence of new strokes in the United States is nearly one half million, with over 3 million stroke survivors alive today. Identifying risk factors for initial ischemic stroke, as well as characterizing the determinants of outcome (stroke recurrence and mortality) after ischemic stroke, is the basis for stroke prevention strategies. Modifiable and nonmodifiable risk factors for ischemic stroke have been identified and include age; gender; race/ethnicity; heredity; hypertension; cardiac disease, particularly atrial fibrillation; diabetes mellitus; hypercholesterolemia; cigarette smoking; and alcohol abuse. New risk factors, such as hypercoagulable states and patient foramen ovale, are currently being investigated. Follow-up studies have quantified case-fatality rates, early recurrence risk, and long-term mortality and recurrence risks. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. A major goal set by the Public Health Service in its National Health Promotion and Disease Prevention Objectives for the year 2000 is "to reduce stroke deaths to no more than 20 per 100,000." Part of this can be achieved if the risk of stroke recurrence is reduced. However, the frequency and determinants of stroke recurrence are poorly understood. Data from epidemiologic studies can help identify risk factors and outcomes after ischemic stroke, as well as the selection of high-risk individuals for focused risk-factor modification. Current information on these topics is discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7885584

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  36 in total

1.  Twenty-Five-Year (1986-2011) Trends in the Incidence and Death Rates of Stroke Complicating Acute Myocardial Infarction.

Authors:  Essa Hariri; Mayra Tisminetzky; Darleen Lessard; Jorge Yarzebski; Joel Gore; Robert Goldberg
Journal:  Am J Med       Date:  2018-05-04       Impact factor: 4.965

2.  Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Maarten G Lansberg; Martin J O'Donnell; Pooja Khatri; Eddy S Lang; Mai N Nguyen-Huynh; Neil E Schwartz; Frank A Sonnenberg; Sam Schulman; Per Olav Vandvik; Frederick A Spencer; Pablo Alonso-Coello; Gordon H Guyatt; Elie A Akl
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Outcomes in severe middle cerebral artery ischemic stroke.

Authors:  Brian P Walcott; Jennifer C Miller; Churl-Su Kwon; Sameer A Sheth; Marc Hiller; Carolyn A Cronin; Lee H Schwamm; J Marc Simard; Kristopher T Kahle; W Taylor Kimberly; Kevin N Sheth
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

4.  Thrombophilia in ischemic stroke.

Authors:  A Potti; K M Rabadi; D D Willardsen
Journal:  West J Med       Date:  1998-12

5.  Infarct volume predicts outcome after decompressive hemicraniectomy for malignant hemispheric stroke.

Authors:  Nils Hecht; Hermann Neugebauer; Ingo Fiss; Alexandra Pinczolits; Peter Vajkoczy; Eric Jüttler; Johannes Woitzik
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-30       Impact factor: 6.200

6.  Accelerated Risk of Premature Ischemic Stroke in 5-Year Survivors of Nasopharyngeal Carcinoma.

Authors:  Min-Chi Chen; Feng-Che Kuan; Shiang-Fu Huang; Chang-Hsien Lu; Ping-Tsung Chen; Cih-En Huang; Ting-Yao Wang; Chih-Cheng Chen; Kuan-Der Lee
Journal:  Oncologist       Date:  2019-03-21

7.  Profile of dementia in a Nigerian community--types, pattern of impairment, and severity rating.

Authors:  A Ogunniyi; O Gureje; O Baiyewu; F Unverzagt; K S Hall; S Oluwole; B O Osuntokun; H C Hendrie
Journal:  J Natl Med Assoc       Date:  1997-06       Impact factor: 1.798

8.  Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia.

Authors:  Hannah X Chu; Hyun Ah Kim; Seyoung Lee; Jeffrey P Moore; Christopher T Chan; Antony Vinh; Mathias Gelderblom; Thiruma V Arumugam; Brad R S Broughton; Grant R Drummond; Christopher G Sobey
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

9.  Characterization of hospitalized ischemic stroke patients in palestine.

Authors:  Af Sawalha
Journal:  Libyan J Med       Date:  2009-03-01       Impact factor: 1.657

10.  Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care.

Authors:  J Berrouschot; M Sterker; S Bettin; J Köster; D Schneider
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.